Holen Sie sich die Stockscreener-App
3.15
1.56%
-0.05
Vorhandelsmarkt:
3.12
-0.03
-0.95%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TPST?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.20
Offen:
$3.22
24-Stunden-Volumen:
75,695
Relative Volume:
0.73
Marktkapitalisierung:
$15.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-43.10M
KGV:
-0.324
EPS:
-9.7212
Netto-Cashflow:
$-36.82M
1W Leistung:
-3.67%
1M Leistung:
-67.82%
6M Leistung:
-64.53%
1J Leistung:
-72.65%
1-Tages-Spanne:
$3.11
$3.22
1-Wochen-Bereich:
$3.04
$3.499
52-Wochen-Spanne:
$3.00
$13.65
Tempest Therapeutics Inc Stock (TPST) Company Profile
Firmenname
Tempest Therapeutics Inc
Sektor
Branche
Telefon
415-798-8589
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE
Vergleichen Sie TPST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
3.15 | 15.77M | 0 | -43.10M | -36.82M | -9.7212 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-08 | Eingeleitet | Jefferies | Buy |
Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten
Tempest Therapeutics (TPST) Stock Price, Quote, News & History - Benzinga
Tempest Therapeutics closes $4.25 million registered direct offering By Investing.com - Investing.com Nigeria
Tempest Therapeutics Closes $4.3 Million Direct Offering - MarketScreener
Tempest Therapeutics closes $4.25 million registered direct offering - Investing.com
Tempest Therapeutics : Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules - MarketScreener
Tempest Therapeutics, Inc. Completes Registered Direct Offering and Private Placement, Raising Approximately $4.25 Million - Quiver Quantitative
Tempest Announces Closing of Up To $8.35 Million Registered - GlobeNewswire
[8-K] Tempest Therapeutics, Inc. Reports Material Event | TPST SEC FilingForm 8-K - Stock Titan
Tempest Therapeutics Secures $4.25M in Direct Offering - MSN
Form 8-KCurrent report - ADVFN
Tempest Therapeutics stock falls after $4.25 million direct offering - MSN
[424B5] Tempest Therapeutics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Form 424B5 Tempest Therapeutics, - StreetInsider
Tempest Therapeutics stock falls after $4.25 million direct offering By Investing.com - Investing.com UK
Tempest Therapeutics raises $4.25 million in registered direct offering - Investing.com
Tempest Therapeutics Inc (TPST) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Tempest Therapeutics raises $4.25 million in registered direct offering By Investing.com - Investing.com India
Tempest Therapeutics (Nasdaq: TPST) prices $4.25M offering with $4.1M warrant upside - Stock Titan
Is Tempest Therapeutics Inc. stock ready for breakoutMarket Growth Report & Growth Oriented Trade Recommendations - newser.com
Will Tempest Therapeutics Inc. stock outperform growth indexesTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Tempest Therapeutics Announces New Leadership and Acquisition - MSN
Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs By Investing.com - Investing.com Australia
Check Out Tempest Therapeutics Inc (TPST)’s Trade Data Rather Than the Analysts’ Views - Setenews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
What technical signals suggest for Tempest Therapeutics Inc. stockJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
Will Tempest Therapeutics Inc. stock go up soonProduct Launch & Safe Entry Trade Signal Reports - newser.com
Tempest Therapeutics Stock Plummets Nearly 50% Amid Shareholder Dilution Fears Following CAR-T Acquisition - Markets Financial Content
Tempest gains CAR Ts for 65% of the company; stock drops - BioWorld MedTech
Why Tempest Therapeutics Inc. stock appeals to dividend seekersQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Tempest Therapeutics to acquire Factor Bioscience's CAR-T programs By Investing.com - Investing.com Nigeria
Is Tempest Therapeutics Inc. stock poised for growthWeekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction - MSN
Tempest Therapeutics to acquire Factor Bioscience’s CAR-T programs - Investing.com India
Tempest Therapeutics stock plunges after all-stock acquisition By Investing.com - Investing.com South Africa
Why Tempest Therapeutics (TPST) Stock Is Down 45% Today - Benzinga
Tempest Therapeutics stock plunges after all-stock acquisition - Investing.com India
Is Tempest Therapeutics Inc. stock undervalued vs historical averages2025 Top Decliners & Expert Approved Trade Ideas - newser.com
Is Tempest Therapeutics Inc. stock cheap at current valuationJuly 2025 Selloffs & Risk Controlled Daily Plans - newser.com
Tempest announces strategic acquisition of new dual-car T programs from Factor with simultaneous runway extension projected to mid 2027 - marketscreener.com
Tempest Therapeutics Announces Executive and Board Changes - TradingView
Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027 - The Globe and Mail
Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):